Status:
UNKNOWN
Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure Management?
Lead Sponsor:
Riverside University Health System Medical Center
Conditions:
Acute Decompensated Heart Failure
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
This study evaluates daily POCUS/FCU exams on patients admitted for acute decompensated heart failure with primary end point of acute kidney injury while in hospital.
Detailed Description
Patients with admitted to hospital with Acute Decompensated Heart failure (ADHF) suffer a significant morbidity and premature mortality. Administration of intravenous (IV) diuretics is largely guided ...
Eligibility Criteria
Inclusion
- Age \>18 admitted for acute decompensated heart failure exacerbation as primary admission diagnosis from Emergency department to General Medicine ward that are administered diuretic therapy expected to be admitted for two days or more.
Exclusion
- Decline consent for study
- If admitted and research team not available for consent and initial evaluation prior within 6 hours of first diuretic administration
- Patients in whom diuretics will not be utilized (i.e. anuric, ESRD on HD)
- Inability to assess IVC (surgical anatomy, body habitus, Ileus, etc.)
- Patients admitted to ICU
- Patients currently on positive pressure ventilation (BiPAP)
- Patients discharged from the emergency department
- Patients discharged prior to evaluation by the POCUS team
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04436718
Start Date
August 1 2019
End Date
July 1 2021
Last Update
June 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
RUHS Medical center
Moreno Valley, California, United States, 92555